News from evofem biosciences, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 11, 2023, 08:00 ET Evofem Biosciences Successfully Amends S.P.A. with Institutional Investor

Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the "Company") today announced it has successfully negotiated and entered into a fourth amendment...

Aug 22, 2023, 16:01 ET Evofem Biosciences Signs Non-Binding Letter of Intent to Enable Listing on a National Stock Exchange

Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the Company) today announced it has signed a confidential non-binding letter of intent (LOI)...

Aug 14, 2023, 17:00 ET Evofem Biosciences Announces Financial Results for the Second Quarter of 2023

...

Jul 06, 2023, 08:42 ET Evofem to Participate in the Virtual Investor Summer Spotlight Series

Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced that Saundra Pelletier, Chief Executive Officer, and Amy Raskopf, Senior Vice ...

Jun 16, 2023, 16:01 ET Evofem Biosciences Announces Financial Results for the First Quarter of 2023

Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced financial results for the first quarter of 2023, including growth in net product sales of its ...

Jun 01, 2023, 08:36 ET Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023

Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced strong preliminary results for the first quarter of 2023, including robust growth in net...

May 17, 2023, 16:50 ET Evofem Biosciences Announces 1-for-125 Reverse Stock Split

Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced a 1-for-125 reverse stock split of the Company's common stock, which was...

Apr 28, 2023, 06:50 ET Evofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Update

Evofem Biosciences, Inc. (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), has reported financial results for...

Apr 14, 2023, 09:00 ET Evofem Appoints Ivy Zhang as Chief Financial Officer and Secretary

Evofem Biosciences, Inc., (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced the appointment of ...

Apr 12, 2023, 08:48 ET Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required

Evofem Biosciences, Inc., (OTCQB: EVFM) today announced a major new win in New York state that improves coverage for Phexxi® (lactic acid, citric...

Mar 21, 2023, 08:48 ET Evofem Biosciences Announces Cost Reduction Measures

Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced it has implemented measures to lower its operating expenses, with the goal of ...

Mar 09, 2023, 06:50 ET Evofem Biosciences Appoints Interim Chief Financial Officer

Evofem Biosciences, Inc. (OTCQB: EVFM) is pleased to announce the appointment of Albert Altro as Interim Chief Financial Officer of the Company. He...

Feb 28, 2023, 08:48 ET Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering

Evofem Biosciences, Inc. (OTCQB: EVFM) announced today that reproductive telehealth leader SimpleHealth now offers Phexxi® (lactic acid, citric acid...

Feb 27, 2023, 07:46 ET Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi

Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that two additional U.S. patents which cover Phexxi® (lactic acid, citric acid and potassium...

Feb 23, 2023, 08:34 ET Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value

Evofem Biosciences, Inc. (OTCQB: EVFM), announced today that its Board of Directors has unanimously approved a comprehensive strategic process to...

Jan 12, 2023, 08:36 ET Evofem's Phexxi Contraceptive Gel to be Offered by Female Telehealth Leader Favor (Formerly The Pill Club)

Evofem Biosciences, Inc. (OTCQB: EVFM) announced today that female telehealth leader Favor is now a specialty pharmacy provider of Phexxi® (lactic...

Jan 10, 2023, 08:36 ET Costco Adds Phexxi® to Member Prescription Program

Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that Phexxi® (lactic acid, citric acid, potassium bitartrate) has been added to the Costco...

Jan 09, 2023, 18:31 ET Multiple New Insurance Wins Expand and Improve Access to Phexxi® for Millions of Women

Evofem Biosciences, Inc. (OTCQB: EVFM) today announced multiple new insurance wins that give millions of additional women access to Phexxi® (lactic...

Dec 29, 2022, 16:48 ET OTC Markets Group Grants Evofem Additional Time to File Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2022

Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that it has been granted additional time by the OTC Markets Group to file its Quarterly Report ...

Oct 11, 2022, 21:00 ET Evofem Reports Top-Line Results from Phase 3 EVOGUARD Clinical Trial Evaluating EVO100 for Prevention of Chlamydia and Gonorrhea Infection in Women

Evofem Biosciences, Inc. (OTCQB: EVFM) announced today that the recently completed Phase 3 EVOGUARD clinical trial evaluating EVO100 for the...

Oct 06, 2022, 08:46 ET Evofem Biosciences Announces Approval of Phexxi in Nigeria

Evofem Biosciences, Inc., (OTCQB: EVFM) today announced that its hormone-free contraceptive vaginal gel has been approved by the Nigerian Regulatory...

Oct 03, 2022, 08:30 ET Evofem Biosciences Announces Uplisting to OTCQB

Evofem Biosciences, Inc., (OTCQB: EVFM) announced today that the trading of its common shares has been upgraded to the OTCQB Venture Market from the...

Sep 23, 2022, 09:00 ET Evofem Announces Issuance of U.S. Patent Covering Phexxi® Composition of Matter

Evofem Biosciences (OTCPK: EVFM) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,439,610,...

Sep 19, 2022, 09:00 ET Inventor of the Year Awarded to Developer of Phexxi®

Evofem Biosciences (OTCPK: EVFM) is pleased to congratulate University of Illinois Chicago (UIC) Professor Emeritus Donald Waller, Ph.D., on his...

Sep 16, 2022, 09:00 ET Large Commercial Payer Adds Phexxi® to Formulary for Standard Plans Nationwide

Evofem Biosciences, Inc. (OTCPK: EVFM) today announced another new insurance win that gives millions of additional women access to Phexxi® (lactic...